Arrowhead Pharmaceuticals, Inc.
ARWR
$21.33
$0.582.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.00% | 98.85% | -18.69% | 55.93% | -16.59% |
| Total Receivables | 310.11% | -5.40% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.32% | 153.78% | -1.79% | 3.58% | -16.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.49% | 75.84% | -7.53% | 32.72% | -34.28% |
| Total Current Assets | -16.59% | 98.97% | -17.96% | 54.53% | -16.91% |
|
|
|||||
| Total Current Assets | -16.59% | 98.97% | -17.96% | 54.53% | -16.91% |
| Net Property, Plant & Equipment | -0.98% | -0.62% | 0.15% | 2.63% | 4.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.51% | -5.24% | -4.96% | -4.73% | -4.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.13% | -57.44% | -31.21% | 0.49% | 2,023.81% |
| Total Assets | -12.26% | 55.22% | -11.06% | 28.97% | -7.47% |
|
|
|||||
| Total Accounts Payable | 231.16% | -30.97% | 26.95% | -57.11% | 211.58% |
| Total Accrued Expenses | -11.55% | 39.06% | -15.72% | 42.29% | 30.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.51% | 776.99% | 29.06% | 4.77% | 14.53% |
| Total Finance Division Other Current Liabilities | -30.34% | 1,362.31% | -35.02% | -36.69% | -6.53% |
| Total Other Current Liabilities | -30.34% | 1,362.31% | -35.02% | -36.69% | -6.53% |
| Total Current Liabilities | -11.79% | 135.22% | -9.12% | 6.67% | 48.39% |
|
|
|||||
| Total Current Liabilities | -11.79% | 135.22% | -9.12% | 6.67% | 48.39% |
| Long-Term Debt | -0.11% | -25.63% | 2.73% | 118.59% | 19.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.71% | -1.62% | -1.56% | -0.90% | -1.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.20% | -7.14% | 0.94% | 74.15% | 18.50% |
|
|
|||||
| Common Stock & APIC | 0.63% | 14.08% | 2.26% | 1.10% | 0.99% |
| Retained Earnings | -12.27% | 20.60% | -10.65% | -11.72% | -13.30% |
| Treasury Stock & Other | 22.03% | 6.12% | -12.91% | 581.26% | 9.86% |
| Total Common Equity | -23.56% | 1,199.36% | -71.64% | -43.90% | -31.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.56% | 1,199.36% | -71.64% | -43.90% | -31.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -377.32% | -74.07% | -37.96% | -33.32% | -27.42% |
| Total Equity | -24.03% | 1,120.20% | -70.65% | -43.63% | -31.58% |
|
|
|||||